AD

Financial statements Inpharm

Balance sheet of Inpharm

Company age:
Age:
13 y. 9 m. 21 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of INPHARM

Year
2018
2019
2020
2021
2022
2023
2024
Total assets 218 338,11 187 682,97 228 894,54 212 190,06 193 997,45 1 031 066,07 1 218 063,92
A. Fixed assets 2 125,00 1 624,99 1 125,00 624,99 124,99 17 633,00 45 194,40
B. Current assets 216 213,11 186 057,98 227 769,54 211 565,07 193 872,46 1 013 433,07 1 172 869,52
C. Share capital contributions (basic funds) - - - - - 0,00 0,00
D. Own shares (stocks) - - - - - 0,00 0,00
Total liabilities 218 338,11 187 682,97 228 894,54 212 190,06 193 997,45 1 031 066,07 1 218 063,92
A. Equity -5 118,66 -67 483,14 -147 081,19 -211 035,83 -210 987,13 -260 344,81 -987 292,87
B. Liabilities and provisions for liabilities 223 456,77 255 166,11 375 975,73 423 225,89 404 984,58 1 291 410,88 2 205 356,79
I. Long-term liabilities 0,00 0,00 17 000,00 - - - 1 397 674,80
II. Short-term liabilities 223 456,77 255 166,11 358 975,73 - - - 787 863,39
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD